beta-lapachone has been researched along with Colorectal Neoplasms in 2 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, EJ | 1 |
| Kim, HJ | 2 |
| Shin, SC | 1 |
| Kim, GS | 1 |
| Jung, JM | 1 |
| Hong, SC | 1 |
| Kim, CW | 1 |
| Lee, WS | 1 |
| Kee, JY | 1 |
| Han, YH | 1 |
| Park, J | 1 |
| Kim, DS | 1 |
| Mun, JG | 1 |
| Ahn, KS | 1 |
| Um, JY | 1 |
| Hong, SH | 1 |
2 other studies available for beta-lapachone and Colorectal Neoplasms
| Article | Year |
|---|---|
β-Lapachone Exerts Anticancer Effects by Downregulating p53, Lys-Acetylated Proteins, TrkA, p38 MAPK, SOD1, Caspase-2, CD44 and NPM in Oxaliplatin-Resistant HCT116 Colorectal Cancer Cells.
Topics: Apoptosis; Caspase 2; Cell Line, Tumor; Colorectal Neoplasms; HCT116 Cells; Humans; Hyaluronan Recep | 2023 |
β-Lapachone Inhibits Lung Metastasis of Colorectal Cancer by Inducing Apoptosis of CT26 Cells.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Prol | 2017 |